| Divergent clonal selection dominates medulloblastoma at recurrence AS Morrissy, L Garzia, DJH Shih, S Zuyderduyn, X Huang, P Skowron, ... Nature 529 (7586), 351-357, 2016 | 348 | 2016 |
| Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer M Wong, C Mayoh, LMS Lau, DA Khuong-Quang, M Pinese, A Kumar, ... Nature medicine 26 (11), 1742-1753, 2020 | 250 | 2020 |
| Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion F Voli, E Valli, L Lerra, K Kimpton, F Saletta, FM Giorgi, D Mercatelli, ... Cancer research 80 (19), 4129-4144, 2020 | 232 | 2020 |
| Genomic profiling of childhood tumor patient-derived xenograft models to enable rational clinical trial design JL Rokita, KS Rathi, MF Cardenas, KA Upton, J Jayaseelan, KL Cross, ... Cell reports 29 (6), 1675-1689. e9, 2019 | 163 | 2019 |
| Spatial heterogeneity in medulloblastoma AS Morrissy, FMG Cavalli, M Remke, V Ramaswamy, DJH Shih, ... Nature genetics 49 (5), 780-788, 2017 | 141 | 2017 |
| Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma LD Gamble, S Purgato, J Murray, L Xiao, DMT Yu, KM Hanssen, ... Science Translational Medicine 11 (477), eaau1099, 2019 | 117 | 2019 |
| Brief report: potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma DS Ziegler, M Wong, C Mayoh, A Kumar, M Tsoli, E Mould, V Tyrrell, ... British Journal of Cancer 119 (6), 693-696, 2018 | 115 | 2018 |
| Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas A Khan, LD Gamble, DH Upton, C Ung, DMT Yu, A Ehteda, R Pandher, ... Nature communications 12 (1), 971, 2021 | 85 | 2021 |
| The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35 PY Liu, AE Tee, G Milazzo, KM Hannan, J Maag, S Mondal, B Atmadibrata, ... Nature communications 10 (1), 5026, 2019 | 80 | 2019 |
| JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma M Wong, Y Sun, Z Xi, G Milazzo, RC Poulos, C Bartenhagen, JL Bell, ... Nature Communications 10 (1), 3319, 2019 | 72 | 2019 |
| Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia D Jing, Y Huang, X Liu, KCS Sia, JC Zhang, X Tai, M Wang, CE Toscan, ... Cancer cell 34 (6), 906-921. e8, 2018 | 70 | 2018 |
| Network modeling of microRNA–mRNA interactions in neuroblastoma tumorigenesis identifies miR-204 as a direct inhibitor of MYCN CY Ooi, DR Carter, B Liu, C Mayoh, A Beckers, A Lalwani, Z Nagy, ... Cancer Research 78 (12), 3122-3134, 2018 | 56 | 2018 |
| Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants AM Bournazos, LG Riley, S Bommireddipalli, L Ades, LS Akesson, ... Genetics in Medicine 24 (1), 130-145, 2022 | 55 | 2022 |
| An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability Z Nagy, JA Seneviratne, M Kanikevich, W Chang, C Mayoh, P Venkat, ... Nature communications 12 (1), 1881, 2021 | 46 | 2021 |
| Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy A Kamili, AJ Gifford, N Li, C Mayoh, SO Chow, TW Failes, GL Eden, ... British journal of cancer 122 (5), 680-691, 2020 | 43 | 2020 |
| Crizotinib and surgery for long-term disease control in children and adolescents with ALK-positive inflammatory myofibroblastic tumors T Trahair, AJ Gifford, A Fordham, C Mayoh, M Fadia, R Lukeis, AC Wood, ... JCO Precision Oncology 3, 1-11, 2019 | 40 | 2019 |
| A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B‐cell acute lymphoblastic leukaemia in children R Sutton, NC Venn, T Law, JM Boer, TN Trahair, A Ng, ML Den Boer, ... British journal of haematology 180 (4), 550-562, 2018 | 40 | 2018 |
| International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma M Tsoli, H Shen, C Mayoh, L Franshaw, A Ehteda, D Upton, D Carvalho, ... Journal of neuro-oncology 141, 253-263, 2019 | 39 | 2019 |
| OBI-3424, a novel AKR1C3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALL K Evans, JX Duan, T Pritchard, CD Jones, L McDermott, Z Gu, CE Toscan, ... Clinical Cancer Research 25 (14), 4493-4503, 2019 | 37 | 2019 |
| Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG A Ehteda, S Simon, L Franshaw, FM Giorgi, J Liu, S Joshi, JRC Rouaen, ... Cell reports 35 (2), 2021 | 33 | 2021 |
